Tomotaka Shingaki

542 total citations
16 papers, 429 citations indexed

About

Tomotaka Shingaki is a scholar working on Pharmaceutical Science, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Tomotaka Shingaki has authored 16 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmaceutical Science, 7 papers in Oncology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Tomotaka Shingaki's work include Drug Transport and Resistance Mechanisms (7 papers), Advanced Drug Delivery Systems (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Tomotaka Shingaki is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Advanced Drug Delivery Systems (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Tomotaka Shingaki collaborates with scholars based in Japan and United Kingdom. Tomotaka Shingaki's co-authors include Shinji Yamashita, Yasuyoshi Watanabe, Toshiyasu Sakane, Ismael J. Hidalgo, Tomoyuki Furubayashi, Hidemasa Katsumi, Yasuhiro Wada, Yuichi Sugiyama, Yumiko Katayama and Akira Yamamoto and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Tomotaka Shingaki

16 papers receiving 419 citations

Peers

Tomotaka Shingaki
Tomotaka Shingaki
Citations per year, relative to Tomotaka Shingaki Tomotaka Shingaki (= 1×) peers Emi Hayashinaka

Countries citing papers authored by Tomotaka Shingaki

Since Specialization
Citations

This map shows the geographic impact of Tomotaka Shingaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomotaka Shingaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomotaka Shingaki more than expected).

Fields of papers citing papers by Tomotaka Shingaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomotaka Shingaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomotaka Shingaki. The network helps show where Tomotaka Shingaki may publish in the future.

Co-authorship network of co-authors of Tomotaka Shingaki

This figure shows the co-authorship network connecting the top 25 collaborators of Tomotaka Shingaki. A scholar is included among the top collaborators of Tomotaka Shingaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomotaka Shingaki. Tomotaka Shingaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Shingaki, Tomotaka, Yumiko Katayama, Takayoshi Nakaoka, et al.. (2016). Exploration of Antiemetics for Osteoporosis Therapy-Induced Nausea and Vomiting Using PET Molecular Imaging Analysis to Gastrointestinal Pharmacokinetics. Pharmaceutical Research. 33(5). 1235–1248. 4 indexed citations
2.
Okauchi, Takashi, Di Hu, Tomotaka Shingaki, et al.. (2016). Extension of recovery time from fatigue by repeated rest with short‐term sleep during continuous fatigue load: Development of chronic fatigue model. Journal of Neuroscience Research. 94(5). 424–429. 6 indexed citations
3.
Kamei, Noriyasu, Tomotaka Shingaki, Yousuke Kanayama, et al.. (2016). Visualization and Quantitative Assessment of the Brain Distribution of Insulin through Nose-to-Brain Delivery Based on the Cell-Penetrating Peptide Noncovalent Strategy. Molecular Pharmaceutics. 13(3). 1004–1011. 34 indexed citations
4.
Shingaki, Tomotaka, W. Ewan Hume, Tadayuki Takashima, et al.. (2015). Quantitative Evaluation of mMate1 Function Based on Minimally Invasive Measurement of Tissue Concentration Using PET with [11C]Metformin in Mouse. Pharmaceutical Research. 32(8). 2538–47. 37 indexed citations
5.
Shingaki, Tomotaka, Yumiko Katayama, Takayoshi Nakaoka, et al.. (2015). Visualization of drug translocation in the nasal cavity and pharmacokinetic analysis on nasal drug absorption using positron emission tomography in the rat. European Journal of Pharmaceutics and Biopharmaceutics. 99. 45–53. 10 indexed citations
6.
Hume, W. Ewan, Tomotaka Shingaki, Tadayuki Takashima, et al.. (2013). The synthesis and biodistribution of [11C]metformin as a PET probe to study hepatobiliary transport mediated by the multi-drug and toxin extrusion transporter 1 (MATE1) in vivo. Bioorganic & Medicinal Chemistry. 21(24). 7584–7590. 30 indexed citations
7.
Shingaki, Tomotaka, Tadayuki Takashima, Xuan Zhang, et al.. (2013). Evaluation of Oatp and Mrp2 Activities in Hepatobiliary Excretion Using Newly Developed Positron Emission Tomography Tracer [11C]Dehydropravastatin in Rats. Journal of Pharmacology and Experimental Therapeutics. 347(1). 193–202. 43 indexed citations
8.
Inoue, Daisuke, Tomoyuki Furubayashi, Ken‐ichi Ogawara, et al.. (2013). <i>In Vitro</i> Evaluation of the Ciliary Beat Frequency of the Rat Nasal Epithelium Using a High-Speed Digital Imaging System. Biological and Pharmaceutical Bulletin. 36(6). 966–973. 20 indexed citations
9.
Takashima, Tadayuki, Tomotaka Shingaki, Yumiko Katayama, et al.. (2013). Dynamic Analysis of Fluid Distribution in the Gastrointestinal Tract in Rats: Positron Emission Tomography Imaging after Oral Administration of Nonabsorbable Marker, [18F]Deoxyfluoropoly(ethylene glycol). Molecular Pharmaceutics. 10(6). 2261–2269. 31 indexed citations
10.
Shingaki, Tomotaka, Yasuhiro Wada, Masaaki Tanaka, et al.. (2012). Imaging of Gastrointestinal Absorption and Biodistribution of an Orally Administered Probe Using Positron Emission Tomography in Humans. Clinical Pharmacology & Therapeutics. 91(4). 653–659. 30 indexed citations
11.
Kataoka, Makoto, Tadayuki Takashima, Tomotaka Shingaki, et al.. (2012). Dynamic Analysis of GI Absorption and Hepatic Distribution Processes of Telmisartan in Rats Using Positron Emission Tomography. Pharmaceutical Research. 29(9). 2419–2431. 15 indexed citations
12.
Shingaki, Tomotaka, Ismael J. Hidalgo, Tomoyuki Furubayashi, et al.. (2011). Nasal Delivery of P-gp Substrates to the Brain through the Nose–Brain Pathway. Drug Metabolism and Pharmacokinetics. 26(3). 248–255. 21 indexed citations
13.
Shingaki, Tomotaka, Daisuke Inoue, Tomoyuki Furubayashi, et al.. (2010). Transnasal Delivery of Methotrexate to Brain Tumors in Rats: A New Strategy for Brain Tumor Chemotherapy. Molecular Pharmaceutics. 7(5). 1561–1568. 55 indexed citations
14.
Shingaki, Tomotaka, Ismael J. Hidalgo, Tomoyuki Furubayashi, et al.. (2009). The transnasal delivery of 5-fluorouracil to the rat brain is enhanced by acetazolamide (the inhibitor of the secretion of cerebrospinal fluid). International Journal of Pharmaceutics. 377(1-2). 85–91. 26 indexed citations
15.
Obradovic, Tanja, et al.. (2006). Assessment of the First and Second Generation Antihistamines Brain Penetration and Role of P-Glycoprotein. Pharmaceutical Research. 24(2). 318–327. 57 indexed citations
16.
Shingaki, Tomotaka, Toshiyasu Sakane, Shinji Yamashita, et al.. (1999). Transnasal delivery of anticancer drugs to the brain tumor. A new strategy for brain tumor chemotherapy.. Drug Delivery System. 14(5). 365–371. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026